Search research articles
Contact Us
Filters
Showing results (231-240 of 251) with videos related to
Page
of 26
Sort By:
ESMO Open
|
April 13, 2024
Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor-stroma ratio in colon cancer
M Polack, M A Smit, G W van Pelt, et al.
ESMO Open
|
November 28, 2023
Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry
N Hindi, A Razak, E Rosenbaum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2014
Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial
A J Breugom, W van Gijn, E W Muller, et al.
ESMO Open
|
June 4, 2024
Sunitinib for the treatment of metastatic gastrointestinal stromal tumors: the effect of TDM-guided dose optimization on clinical outcomes
E L Giraud, K Westerdijk, M B A van der Kleij, et al.
Nature
|
October 2, 2019
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
D L van der Velden, L R Hoes, H van der Wijngaart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 26, 2014
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment
J S Whelan, S S Bielack, N Marina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
C A Bellera, N Penel, M Ouali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
G D Demetri, C R Antonescu, B Bjerkehagen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2026
Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study
A Bonetti, V L Le, Z I Carrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2017
Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group
S Stacchiotti, A Gronchi, P Fossati, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 251) with videos related to
Sort By:
Page
of 26
ESMO Open
|
April 13, 2024
Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor-stroma ratio in colon cancer
M Polack, M A Smit, G W van Pelt, et al.
ESMO Open
|
November 28, 2023
Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry
N Hindi, A Razak, E Rosenbaum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2014
Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial
A J Breugom, W van Gijn, E W Muller, et al.
ESMO Open
|
June 4, 2024
Sunitinib for the treatment of metastatic gastrointestinal stromal tumors: the effect of TDM-guided dose optimization on clinical outcomes
E L Giraud, K Westerdijk, M B A van der Kleij, et al.
Nature
|
October 2, 2019
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
D L van der Velden, L R Hoes, H van der Wijngaart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 26, 2014
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment
J S Whelan, S S Bielack, N Marina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
C A Bellera, N Penel, M Ouali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
G D Demetri, C R Antonescu, B Bjerkehagen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2026
Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study
A Bonetti, V L Le, Z I Carrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2017
Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group
S Stacchiotti, A Gronchi, P Fossati, et al.
Page
of 26